Endothelin-1 and CYP450 arachidonate metabolites interact to promote tissue injury in DOCA-salt hypertension

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 276, Issue 3 45-3, 1999, Pages

  Oyekan, A O ^a   Mcaward, K ^a   Conetta, J ^a   Rosenfeld, L ^a   Mcgiff, John C ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

20 hydroxyeicosatetraenoic acid; Cardiovascular hypertrophy; Cobalt chloride; Cytochrome P 450

Indexed keywords

ARACHIDONIC ACID; CYTOCHROME P450; DEOXYCORTICOSTERONE ACETATE; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR;

ANIMAL EXPERIMENT; ARACHIDONIC ACID METABOLISM; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT; SECOND MESSENGER;

EID: 0032952056     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.1999.276.3.r766     Document Type: Article

References (39)

1. Bazil, M. K., R. W. Lappe, and R. L. Webb. Pharmacological characterization of an endothelin A receptor antagonist in conscious rats. J. Cardiovasc. Pharmacol. 20: 940-948, 1992.
2. Burns, K. D., J. Capdevilla, S. Wei, M. D. Breyer, T. Homma, and R. C. Harris. Role of cytochrome P-450 epoxygenase metabolites in epidermal growth factor signaling in renal proximal tubules. Am. J. Physiol. 269 (Cell Physiol. 38): C831-C840, 1995.
3. Capdevilla, J. H., J. R. Falck, and R. W. Estabrook. Cytochrome P-450 and the arachidonic acid cascade. FASEB J. 6: 731-736, 1992.
4. Capdevilla, J. H., S. Wei, J. Yan, A. Karara, H. R. Jacobson, J. R. Falck, F. P. Guengerich, and R. N. DuBois. Cytochrome P-450 arachidonic acid epoxygenase. Regulatory control of the renal epoxygenase by dietary salt loading. J. Biol. Chem. 267: 21720-21726, 1992.
5. Carroll, M. A., M. Balazy, D.-D. Huang, S. Rybalova, J. R. Falck, and J. C. McGiff. Cytochrome P450-derived renal HETEs: storage and release. Kidney Int., 51: 1696-1702, 1997.
6. Carroll, M. A., A. Sala, C. E. Dunn, J. C. McGiff, and R. C. Murphy. Structural identification of cytochrome P450-dependent arachidonate metabolites formed by rabbit medullary thick ascending limb cells. J. Biol. Chem. 266: 12306-12312, 1991.
7. Carroll, M. A., M. Schwartzman, M. Baba, M. J. S. Miller, and J. C. McGiff. Renal cytochrome P-450-related arachidonate metabolism in rabbit aortic coarctation. Am. J. Physiol. 255 (Renal Fluid Electrolyte Physiol. 24): F151-F157, 1988.
8. Da Silva, J. L., M. Tiefenthaler, E. Park, B. Escalante, M. L. Schwartzman, R. D. Levere, and N. G. Abraham. Tin-mediated heme oxygenase gene activation and cytochrome P450 arachidonate hydroxylase inhibition in spontaneously hypertensive rats. Am. J. Med. Sci. 307: 173-181, 1994.
9. DeMey, J. G. R., M. P. Uitendaal, H. C. M. Boonen, P. M. H. Schiffers, and G. E. Fazzi. Growth responses in isolated elastic, muscular and resistance-sized arterial segments of the rat. Blood Vessels 28: 372-385, 1991.
10. Escalante, B., D. Sacerdoti, M. M. Davidian, M. L. Schwartzman, J. C. McGiff. Chronic treatment with tin normalizes blood pressure in spontaneously hypertensive rats. Hypertension 17: 776-779, 1991.
11. Imaoka, S., Y. Yamazoe, R. Kato, and Y. Funae. Hormonal regulation of rat cytochrome P450s by androgen and pituitary. Arch. Biochern. Biophys. 299: 179-184, 1992.
12. Johnson, R. A., M. Lavesa, B. Askari, N. G. Abraham, and A. Nasjletti. A heme oxygenase product, presumably carbon monoxide, mediates a vasodepressor function in rats. Hypertension 25: 166-169, 1995.
13. Lapuerta, L., N. Chacos, J. R. Falck, H. Jacobson, and J. H. Capdevilla. Renal microsomal cytochrome P450 and the oxidative metabolism of arachidonic acid. Am. J. Med. Sci. 295: 275-279, 1988.
14. Lariviere, R., R. Day, and E. L. Schiffrin. Increased expression of endothelin-1 gene in blood vessels of deoxycorticosterone acetate-salt hypertensive rats. Hypertension 21: 916-920, 1993.
15. Lariviere, R., G. Thibault, and E. L. Schiffrin. Increased endothelin-1 content in blood vessels of deoxycorticosterone acetate-salt hypertensive rats but not in spontaneously hypertensive rats. Hypertension 21: 294-300, 1993.
16. Lin, F., A. Rios, J. R. Falck, Y. Belosludtsev, and M. L. Schwartzman. 20-Hydroxyeicosatetraenoic acid is formed in response to EGF and is a mitogen in rat proximal tubule. Am. J. Physiol. 269 (Renal Fluid Electrolyte Physiol. 38): F806-F816, 1995.
17. + channel in the thick ascending limb of the rat kidney. J. Gen. Physiol. 108: 537-547, 1996.
18. Ma, Y. H., M. L. Schwartzman, and R. J. Roman. Altered renal P-450 metabolism of arachidonic acid in Dahl salt-sensitive rats. Am. J. Physiol. 267 (Regulatory Integrative Comp. Physiol. 36): R579-R589, 1994.
19. Makita, K., K. Takahashi, A. Karara, H. R. Jacobson, J. R. Falck, and J. H. Capdevilla. Experimental and/or genetically controlled alterations of the renal microsomal cytochrome P450 epoxygenase induced hypertension in rats fed a high salt diet. J. Clin. Invest. 94: 2414-2420, 1994.
20. McGiff, J. C. Cytochrome P-450 metabolism of arachidonic acid. Annu. Rev. Pharmacol. Toxicol. 31: 339-369, 1991.
21. Meschter, C. L., B. A. Mico, M. Mortillo, D. Feldman, W. A. Garland, J. A. Riley, and L. S. Kaufman. A 13-week toxicologic and pathologic evaluation of prolonged cytochromes P450 inhibition by 1-aminobenzotriazole in male rats. Fund. Appl. Toxicol. 22: 369-381, 1994.
22. Okita, J. R., P. J. Castle, and R. T. Okita. Characterization of cytochromes P450 in liver and kidney of rats treated with di-(2-ethylhexyl)phthalate. J. Biochem. Toxicol. 8: 135-144, 1993.
23. Omata, K., N. G. Abraham, B. Escalante, and M. L. Schwartzman. Age-related changes in renal cytochrome P-450 arachidonic acid metabolism in spontaneously hypertensive rats. Am. J. Physiol. 262 (Renal Fluid Electrolyte Physiol. 31): F8-F16, 1992.
24. Omata, K., N. G. Abraham, and M. L. Schwartzman. Renal cytochrome P-450-arachidonic acid metabolism: localization and hormonal regulation in SHR. Am. J. Physiol. 262 (Renal Electrolyte Fluid Physiol. 31): F591-F599, 1992.
25. Oyekan, A., M. Balazy, and J. C. McGiff. Renal oxygenases: differential contribution to vasoconstriction induced by ET-1 and angiotensin II. Am. J. Physiol. 273 (Regulatory Integrative Comp. Physiol. 42): R293-R300, 1997.
26. Oyekan, A. O., and J. C. McGiff. Cytochrome P-450-derived eicosanoids participate in the renal functional effects of endothelin-1 in the anesthetized rat. Am. J. Physiol. 274 (Regulatory Integrative Comp. Physiol. 43): R52-R61, 1998.
27. Oyekan, A. O., J. C. McGiff, and J. Quilley. Cytochrome P-450-dependent vasodilation of rat kidney by arachidonic acid. Am. J. Physiol. 261 (Heart Circ. Physiol. 30): H714-H719, 1991.
28. Penney, D. G. Review: hemodynamic response to carbon monoxide. Exp. Health Perspectives 77: 121-130, 1988.
29. Reantragoon, S., L. M. Arrigo, M. M. Abou Seoud, H. S. Dweck, and L. Rosenfeld. Specific heparin fractions suppress endothelin-1 production in cultured human umbilical vein endothelial cells. Arch. Biochem. Biophys. 314: 315-322, 1994.
30. Richard, V., M. Hogie, M. Clozel, B.-M. Loffler, and C. Thuillez. In vivo evidence of an endothelin-induced vasopressor tone after inhibition of nitric oxide synthesis in rats. Circulation 91: 771-775, 1995.
31. Sacerdoti, D., M. Balazy, P. Angeli, A. Gatta, and J. C. McGiff. Eicosanoid excretion in hepatic cirrhosis: predominance of 20-HETE. J. Clin. Invest. 100: 1264-1270, 1997.
32. Sacerdoti, D., B. A. Escalante, N. G. Abraham, J. C. McGiff, R. D. Levere, and M. L. Schwartzman. Treatment with tin prevents the development of hypertension in spontaneously hypertensive rats. Science 243: 388-390, 1989.
33. Schiffrin, E. L., R. Lariviere, L. S. Li, and P. Sventek. Enhanced expression of the endothelin-1 gene in blood vessels of DOCA-salt hypertensive rats: correlation with vascular structure. J. Vasc. Res. 33: 235-248, 1996.
34. Sellmayer, A., W. M. Uedelhoven, P. C. Weber, and J. V. Bonventre. Endogenous non-cyclooxygenase metabolites of arachidonic acid modulate growth and mRNA levels of immediate-early response genes in rat mesangial cells. J. Biol. Chem. 266: 3800-3807, 1991.
35. Takahashi, K., R. C. Harris, J. H. Capdevilla, A. Karara, K. Makita, H. R. Jacobson, K. A. Munger, and K. F. Badr. Induction of renal arachidonate cytochrome P450-epoxygenase after uninephrectomy: counterregulation of hyperfiltration. J. Am. Soc. Nephrol. 3: 1496-1500, 1993.
36. Turner, A. J. Endopeptidase-24.11 and neuropeptide metabolism. In: Neuropeptides and Their Peptidases, edited by A. J. Turner. Chicester, UK: Ellis-Horwood, 1987, p. 183-201 (Health Science Ser.).
37. Uddin, M. R., M. M. Muthalif, N. A. Karzoun, I. F. Benter, and K. U. Malik. Cytochrome P-450 metabolites mediate norepinephrine-induced mitogenic signaling. Hypertension 31: 242-247, 1998.
38. Wang, M.-H., E. Brand-Schieber, B. A. Zand, X. Nguyen, J. R. Falck, N. Balu, and M. L. Schwartzman. Cytochrome P450-derived arachidonic acid metabolism in the rat kidney: characterization of selective inhibitors. J. Pharmacol. Exp. Ther. 284: 966-973, 1998.
39. Yao, A., and D. H. Wang. Heterogeneity of adenovirus-mediated gene transfer in cultured thoracic aorta and renal artery of rats. Hypertension 26: 1046-1050, 1995.